Bernstein's recent analysis suggests Siemens and Avenue Supermarts (DMart) are priced for long-term growth that far exceeds their projected near-term profit performance. The report highlights a gap between current market expectations and forecasted EBITDA growth through FY28. For investors, these findings serve as a cautionary signal, as stocks trading at significant valuation premiums have historically shown a higher tendency to underperform.
A new valuation analysis from brokerage firm Bernstein has identified a sharp divide between market expectations and near-term financial projections for several prominent Indian companies. By using a reverse discounted cash flow (DCF) model, the study compares the long-term growth currently priced into stock prices through 2040 against forecasted EBITDA growth for the 2026-2028 period. This approach aims to highlight companies that may be trading at premiums or discounts relative to their expected operational performance.
Stocks Priced for High Expectations
Bernstein identifies companies where the market is assuming long-term growth rates significantly higher than the company's own near-term earnings potential. Siemens is cited as an extreme example, with a market-implied long-term growth expectation of 44.4%, which stands in contrast to its projected EBITDA growth of 17% for the FY26-28 period. Similarly, Avenue Supermarts (DMart) is shown to have an implied growth expectation of 42.7% against a projected EBITDA growth of 18.7%.
Other companies categorized as highly valued include Asian Paints, United Spirits, Pidilite Industries, Page Industries, and Trent. Bernstein notes that these stocks are often concentrated in sectors perceived as structurally expensive, with the cement sector currently trading at historically high valuation levels and the staples sector remaining in an expensive zone.
Contrasting View on Low-Valuation Stocks
On the other side of the analysis, the brokerage points to stocks where near-term EBITDA growth projections outpace the growth rates currently baked into their stock prices. Aditya Birla Fashion and Retail (ABFRL) tops this list, with a projected EBITDA growth of 28.1% compared to a market-implied rate of 7.2%. KEC International, Torrent Pharmaceuticals, Devyani International, GAIL, and Sun Pharma are also listed in this cluster.
It is important for investors to note that Bernstein cautions against interpreting these low-valuation metrics as immediate buy signals. The report suggests that the market may be discounting these stocks for specific fundamental or structural reasons, such as execution risks, competitive pressures, or industry-specific challenges that may not be captured by near-term growth numbers alone.
Historical Performance Context
Investors should consider the historical reliability of these signals. According to the analysis, stocks flagged as overly expensive relative to their sector average have underperformed in the following 12 months in approximately 64% of observed cases. In comparison, the signals for cheaper stocks have been less consistent, resulting in outperformance only 53% of the time. This suggests that while caution for high-valuation stocks is statistically more reliable, lower valuations alone do not guarantee future stock price gains. Investors may monitor how these companies manage their profit margins and capital spending in the coming quarters to see if they can bridge the gap between market expectations and operational results.